流感疫苗接种和痴呆的风险:一个系统的审查和元分析
Wen-Kang Yang1,2, Shih-Chieh Shao3,4, Chia-Chao Liu3
1Department of Education, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Age and ageing
|July 2, 2025
概括
接种流感疫苗可能会降低痴呆症的风险,特别是在高危人群中. 多重剂量显示出更强的保护作用,表明用于预防痴呆症的剂量反应关系.
科学领域:
- 老年学是指老年学的学科.
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 流感疫苗接种和痴呆风险之间的联系仍然不清楚,有相互矛盾的证据.
- 痴呆症高风险人群包括患有慢性病 (CKD),慢性阻塞性肺病 (COPD) 和血管疾病的人群.
研究的目的:
- 调查流感疫苗接种与痴呆风险之间的关联.
- 评估这一关联在一般人群和特定高风险群体.
主要方法:
- 对队列研究进行系统审查和元分析.
- 在PubMed,Embase和CENTRAL数据库中进行了搜索.
- 使用纽卡斯尔-太华尺度评估偏差风险.
主要成果:
- 包括8项涉及近1000万受试者的队列研究.
- 流感疫苗接种与高风险人群的痴呆风险降低有关,但不是整个人口.
- 在高危人群中观察到剂量-反应关系,更多的剂量与较低的痴呆风险相关.
结论:
- 流感疫苗接种与发生痴呆症的风险降低有关.
- 保护作用似乎取决于剂量,特别是在高危人群中.
更多相关视频
相关概念视频
Vaccinations
45.3K
Overview
45.3K
Bias in Epidemiological Studies
666
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
666
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Confounding in Epidemiological Studies
258
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
258


